Overview
- 6 inspections across 4 sites are on record.
- 0 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2022-10-28.
At a glance
Inspections
6
Sites
4
Observations
0
Career since
Sep 2017
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| Sanofi Vaccines Canada Ltd. | 28 Oct 2022 | Biologics | On file |
| MassBiologics | 19 Nov 2019 | Biologics | On file |
| Sanofi Vaccines Canada Ltd. | 11 Oct 2019 | Biologics | On file |
| GlaxoSmithKline Biologicals SA | 24 Jun 2019 | Biologics | On file |
| GlaxoSmithKline Biologicals SA | 24 Jun 2019 | Biologics | On file |
Sites inspected
Sanofi Vaccines Canada Ltd.North York, Canada2 insp.
MassBiologicsBoston, United States1 insp.
GlaxoSmithKline Biologicals SAWavre, Belgium1 insp.
GlaxoSmithKline Biologicals SARixensart, Belgium1 insp.
Co-investigators
Investigators who share inspections with this person.
Susan M Jackson4 shared
Debra M Emerson3 shared
Shuang Tang2 shared
Eric Peng1 shared
Roger F Zabinski1 shared
Anita Verma1 shared
Lindsey R Lyman1 shared
Donald L Lech1 shared
Janet L Bowen1 shared
Joan Johnson1 shared
Full investigator report
Get the verbatim findings behind Leslie D Wagner's inspection record
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site